Darier and Ferrand dermatofibrosarcoma of the breast
Nora Naqos
The Pan African Medical Journal. ;31:179. doi:10.11604/pamj..31.179.14998

Create an account  |  Sign in
PAMJ - Clinical Medicine PAMJ - Clinical Medicine
"Better health through knowledge sharing and information dissemination "

Images in clinical medicine

Darier and Ferrand dermatofibrosarcoma of the breast

Nora Naqos
Pan Afr Med J. 2018; 31:179. doi:10.11604/pamj.2018.31.179.14998. Published 14 Nov 2018



Darier and Ferrand dermatofibrosarcoma (DFS) is a cutaneous mesenchymal tumor, rare, representing 0.1% of malignant skin tumors and less than 5% of adult soft tissue sarcomas. The favorite sites are the trunk, followed by the extremities proximal then the head and neck. It often occurs in patients in their 3rd-4th diecades and presents clinically as plate or nodule lesion. It is a tumor with intermediate malignancy potential, good prognosis after complete resection, slow growth, very high risk of local reccurence, but with low metastatic potential. Due to its rarity, very few studies have been devoted to it. We report an exceptional localization revealed by a mass in the breast. It is a 43-years-old patient who has consulted for an increase in the volume of the right breast, the clinical examination finds a mass ulcero-budding of 12cm/10cm. The biopsy shows the presence of an histiocytofibroma, a mastectomy was performed, and the histopathological examination with immunohistochemistry showed an intense and diffuse CD34 positivity, a focal positivity of AML (smooth muscle actin) and a constant negativity of desmin and PS100 thus confirming that it is a DFS. CT scan does not find any metastasis and a surveillance was adopted. It is a rare tumor and our observation is among of the first cases of mammary siege described in the literature. The main treatment remains a large surgery with margins of resection of at least 4 to 5 cm, postoperative radiotherapy is advocated by second reccurence. Systemic chemotherapy is not recommended, rigorous clinical practice must be maintained, because of slow evolution and high reccurence of this tumor.


Corresponding author:
Nora Naqos, Department of Medical Oncology, Mohammed VI University Hospital, Marrakech, Morocco
noura.naqos@gmail.com

©Nora Naqos et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More images in clinical medicine

 
 
 
 
 
 
 
 
    






PAMJ Images in Medicine and Public Health are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 34 (September - December 2019)

This image


Share this image:

Filter images [Reset filter]

By language

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2019 - Pan African Medical Journal. All rights reserved